The significance of parenchymal changes of acute cellular rejection in predicting chronic liver graft rejection

Transplantation

Volumn 73, Issue 2, 2002, Pages 243-247

  Gouw, Annette S H ^a   Van den Heuvel, Marius C ^a   Van den Berg, Aad P ^a   Slooff, Maarten J H ^a   De Jong, Koert P ^a   Poppema, Sibrand ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ALLOGRAFT; ARTICLE; CENTRAL VEIN; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; FIBROSIS; FOLLOW UP; GRAFT REJECTION; HEPATITIS; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFANT; LIVER BIOPSY; LIVER NECROSIS; LIVER PARENCHYMA; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL;

EID: 0037180911     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200201270-00016     Document Type: Article

References (20)

1. Evolving concepts in the diagnosis, pathogenesis, and treatment of chronic hepatic allograft rejection
2. Update of the International Banff Schema for liver allograft rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection
3. Analysis of the reversibility of chronic liver allograft rejection implications for a staging schema
4. Chronic rejection after liver transplantation: A study of clinical, histopathological and immunological features
5. Vanishing bile duct syndrome following liver transplantation: Is it reversible?
6. Terminology for hepatic allograft rejection
7. Incidence, timing and risk factors for acute and chronic rejection
8. Banff schema for grading liver allograft rejection: An international consensus document
9. Chronic hepatitis: An update on terminology and reporting
10. Severe ductopenic rejection following liver transplantation: Incidence, time of onset, risk factors, treatment and outcome
11. Orthotopic liver transplantation: A pathologic study of 63 serial liver biopsies from 17 patients with specific reference to the diagnostic features and natural history of rejection
12. Fibrous obliterative lesions of veins contribute to progressive fibrosis in chronic liver allograft rejection
13. "Silent" presentation of venoocclusive disease after liver transplantation as part of the process of cellular rejection with endothelial predilection
14. Prognostic implications of centrilobular necrosis in pediatric liver transplant recipients
15. Centrilobular necrosis after orthotopic liver transplantation: A longitudinal clinicopathologic study in 71 patients
16. Clinicopathological analysis of liver allograft biopsies with late centrilobular necrosis: A comparative study in 54 patients
17. Development of ductopaenic liver allograft rejection includes a "hepatitic" phase prior to duct loss
18. Intrahepatic proliferation of "naïve" and "memory" T cells during liver allograft rejection: Primary immune response within the allograft
19. A quantitative analysis of T lymphocyte populations in human liver allografts undergoing rejection: The use of monoclonal antibodies and double immunolabeling
20. CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface Fas ligand expression and amplifies Fasmediated hepatocyte death during allograft rejection